Advertisement
U.S. markets open in 3 hours 19 minutes

Nektar Therapeutics (NKTR)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
0.6610-0.0290 (-4.20%)
At close: 04:00PM EST
0.6601 -0.00 (-0.14%)
Pre-Market: 05:26AM EST
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Bullishpattern detected
Momentum

Momentum

Previous Close0.6900
Open0.6888
Bid0.0000 x 800
Ask0.0000 x 900
Day's Range0.6500 - 0.7265
52 Week Range0.4100 - 1.8200
Volume999,612
Avg. Volume1,185,296
Market Cap126.1M
Beta (5Y Monthly)0.78
PE Ratio (TTM)N/A
EPS (TTM)-1.5500
Earnings DateFeb 26, 2024 - Mar 01, 2024
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est1.75
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
Overvalued

Subscribe to Yahoo Finance Plus to view Fair Value for NKTR

View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • Nektar Therapeutics
    NKTR: Lowering target price to $0.58NEKTAR THERAPEUTICS has an Investment Rating of SELL; a target price of $0.584000; an Industry Subrating of Medium; a Management Subrating of Low; a Safety Subrating of Low; a Financial Strength Subrating of Low; a Growth Subrating of Low; and a Value Subrating of Low.
    Rating
    Fair Value
    Economic Moat
    11 months agoArgus Research
View more